CZ20014614A3 - Terapeutické činidlo - Google Patents

Terapeutické činidlo Download PDF

Info

Publication number
CZ20014614A3
CZ20014614A3 CZ20014614A CZ20014614A CZ20014614A3 CZ 20014614 A3 CZ20014614 A3 CZ 20014614A3 CZ 20014614 A CZ20014614 A CZ 20014614A CZ 20014614 A CZ20014614 A CZ 20014614A CZ 20014614 A3 CZ20014614 A3 CZ 20014614A3
Authority
CZ
Czechia
Prior art keywords
obesity
formula
compound
lipase inhibitor
methyl
Prior art date
Application number
CZ20014614A
Other languages
Czech (cs)
English (en)
Inventor
Alan Martin Birch
David John Heal
Original Assignee
Abbott Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Gmbh & Co. Kg filed Critical Abbott Gmbh & Co. Kg
Publication of CZ20014614A3 publication Critical patent/CZ20014614A3/cs

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CZ20014614A 1999-06-24 2000-06-16 Terapeutické činidlo CZ20014614A3 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9914742.3A GB9914742D0 (en) 1999-06-24 1999-06-24 Therapeutic agents

Publications (1)

Publication Number Publication Date
CZ20014614A3 true CZ20014614A3 (cs) 2004-02-18

Family

ID=10855953

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20014614A CZ20014614A3 (cs) 1999-06-24 2000-06-16 Terapeutické činidlo

Country Status (20)

Country Link
EP (1) EP1189638A2 (pt)
JP (1) JP2003503344A (pt)
KR (1) KR20020012293A (pt)
CN (1) CN1365287A (pt)
AU (1) AU5815100A (pt)
BG (1) BG106209A (pt)
BR (1) BR0011884A (pt)
CA (1) CA2376213A1 (pt)
CZ (1) CZ20014614A3 (pt)
GB (1) GB9914742D0 (pt)
HK (1) HK1050476A1 (pt)
HU (1) HUP0201880A3 (pt)
IL (1) IL147078A0 (pt)
MX (1) MXPA01013023A (pt)
NO (1) NO20016301L (pt)
PL (1) PL352387A1 (pt)
SK (1) SK18822001A3 (pt)
TR (1) TR200103704T2 (pt)
WO (1) WO2001000187A2 (pt)
ZA (1) ZA200110046B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399826B1 (en) * 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
US7089666B2 (en) * 2003-06-06 2006-08-15 The Regents Of The University Of California Microfabricated vertical comb actuator using plastic deformation
CN101626768B (zh) 2006-09-15 2013-08-21 雷维瓦药品公司 环烷基甲胺的合成、使用方法和组合物
CN101890017A (zh) * 2009-05-22 2010-11-24 北京奥萨医药研究中心有限公司 含有西布曲明和他汀类降脂药物的药物组合物及其用途
WO2012003501A2 (en) 2010-07-02 2012-01-05 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives
BR112014016122A8 (pt) 2011-12-30 2017-07-04 Reviva Pharmaceuticals Inc composto, e, composição farmacêutica

Also Published As

Publication number Publication date
CA2376213A1 (en) 2001-01-04
WO2001000187A3 (en) 2001-11-15
NO20016301D0 (no) 2001-12-21
MXPA01013023A (es) 2003-08-01
SK18822001A3 (sk) 2003-04-01
IL147078A0 (en) 2002-08-14
WO2001000187A2 (en) 2001-01-04
BG106209A (en) 2002-09-30
HUP0201880A2 (hu) 2002-12-28
EP1189638A2 (en) 2002-03-27
JP2003503344A (ja) 2003-01-28
HK1050476A1 (zh) 2003-06-27
HUP0201880A3 (en) 2003-03-28
AU5815100A (en) 2001-01-31
KR20020012293A (ko) 2002-02-15
GB9914742D0 (en) 1999-08-25
TR200103704T2 (tr) 2002-05-21
PL352387A1 (en) 2003-08-25
NO20016301L (no) 2001-12-21
ZA200110046B (en) 2003-03-06
CN1365287A (zh) 2002-08-21
BR0011884A (pt) 2003-08-12

Similar Documents

Publication Publication Date Title
US20030130355A1 (en) Therapeutic agents
RU2197959C2 (ru) Применение аналогов сибутрамина для снижения уровней липидов
EP1039900B1 (en) Pharmaceutical composition containing sibutramine and orlistat
JP2010506845A (ja) フェニルアルキルアミノカルバメート組成物
SK32199A3 (en) Use of sibutramine analogues for producing drug to lower uric acid levels and pharmaceutical composition containing mentioned analogues
US6376552B1 (en) Treatment of gallstones
CZ20014614A3 (cs) Terapeutické činidlo
SK18242001A3 (sk) Terapeutické prípravky na báze sibutramínu vrátane jeho enantiomérov a farmaceuticky prijateľných solí a orlistatu a ich použitie
US6346549B1 (en) Treatment of pharmacology of drug misuse and other addictive disorders
AU773490B2 (en) Treatment of osteoarthritis
US3961073A (en) Antidepressant
US6433020B1 (en) Treatment of cardiovascular disease
MXPA00006201A (en) Pharmaceutical composition containing sibutramine and orlistat
EP1165060A1 (en) Treatment of gallstones
CZ20013282A3 (cs) Farmaceutická kompozice
JP2008255058A (ja) 睡眠障害予防治療剤
JP2008303146A (ja) 睡眠障害予防治療剤
AU2003262286A2 (en) Novel Effectors of Dipeptidyl Peptidase IV